SEC CIK 1885912
Hardin Stacy D.
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| MXCview stock → | 8,327 | 2024-04-15 |
Position History — MXC
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — MXC
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2024-04-15 | Option exercise (out-of-money) (derivative) | 351 | $3.34 | 17,502 |
| 2024-04-15 | Grant / award (derivative) | 147 | $8.51 | 17,853 |
| 2024-04-15 | Option exercise | 351 | $3.34 | 8,327 |
| 2024-04-15 | Open-market sale | 147 | $16.52 | 8,678 |
| 2024-04-15 | Option exercise | 147 | $8.51 | 8,678 |
| 2024-04-09 | Grant / award (derivative) | 800 | $4.84 | 18,000 |
| 2024-04-09 | Open-market sale | 200 | $13.38 | 7,099 |
| 2024-04-09 | Open-market sale | 100 | $13.39 | 7,299 |
| 2024-04-09 | Open-market sale | 300 | $13.34 | 7,399 |
| 2024-04-09 | Open-market sale | 200 | $13.35 | 7,699 |
| 2024-04-09 | Option exercise | 800 | $4.84 | 7,899 |
| 2024-04-08 | Grant / award (derivative) | 450 | $4.84 | 18,800 |
| 2024-04-08 | Open-market sale | 450 | $13.34 | 7,899 |
| 2024-04-08 | Option exercise | 450 | $4.84 | 8,349 |
| 2023-04-12 | Grant / award (derivative) | 5,500 | $12.68 | 19,250 |
| 2022-08-22 | Grant / award (derivative) | 5,000 | $18.05 | 13,750 |
| 2022-03-07 | Grant / award (derivative) | 750 | $4.84 | 8,750 |
| 2022-03-07 | Open-market sale | 375 | $32.00 | 849 |
| 2022-03-07 | Open-market sale | 375 | $30.00 | 1,224 |
| 2022-03-07 | Option exercise | 750 | $4.84 | 1,599 |
| 2022-03-04 | Grant / award (derivative) | 2,500 | $3.34 | 9,500 |
| 2022-03-04 | Open-market sale | 500 | $21.29 | 1,599 |
| 2022-03-04 | Open-market sale | 1,000 | $21.71 | 2,099 |
| 2022-03-04 | Open-market sale | 1,000 | $18.00 | 3,099 |
| 2022-03-04 | Option exercise | 2,500 | $3.34 | 4,099 |
| 2022-03-01 | Grant / award (derivative) | 1,000 | $4.84 | 12,000 |
| 2022-03-01 | Open-market sale | 1,000 | $15.00 | 2,849 |
| 2022-03-01 | Option exercise | 1,000 | $4.84 | 3,849 |
| 2022-02-28 | Grant / award (derivative) | 1,000 | $4.84 | 13,000 |
| 2022-02-28 | Open-market sale | 1,000 | $13.50 | 3,849 |
| 2022-02-28 | Option exercise | 1,000 | $4.84 | 4,849 |
| 2022-02-23 | Grant / award (derivative) | 1,000 | $4.84 | 14,000 |
| 2022-02-23 | Open-market sale | 1,000 | $12.00 | 4,849 |
| 2022-02-23 | Option exercise | 1,000 | $4.84 | 5,849 |
| 2021-10-04 | Grant / award (derivative) | 3,500 | $7.00 | 15,000 |
| 2021-10-04 | Grant / award (derivative) | 1,600 | $5.98 | 18,500 |
| 2021-10-04 | Open-market sale | 1,500 | $15.31 | 5,849 |
| 2021-10-04 | Open-market sale | 2,000 | $14.11 | 7,349 |
| 2021-10-04 | Open-market sale | 1,000 | $12.25 | 9,349 |
| 2021-10-04 | Open-market sale | 600 | $12.21 | 10,349 |
| 2021-10-04 | Option exercise | 1,600 | $5.98 | 10,949 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.